Evaluating Optimal Cost-Effectiveness of Demand Response in Wholesale Markets

被引:0
|
作者
Negash, Ahlmahz I. [1 ]
Westgaard, Sjur [2 ]
机构
[1] Tacoma Power, Energy Resource Planning & Anal, Tacoma, WA 98409 USA
[2] Norwegian Univ Sci & Technol, Ind Econ & Technol Management, Trondheim, Norway
关键词
D O I
暂无
中图分类号
TE [石油、天然气工业]; TK [能源与动力工程];
学科分类号
0807 ; 0820 ;
摘要
Economic demand response (DR) is intended to lower locational marginal prices (LMP) in wholesale energy markets during peak hours. DR resources are paid LMP and that cost is allocated to energy buyers. Market operators use a "net benefits test" to determine if DR is cost effective. This test identifies the LMP threshold below which DR is not cost effective; however, it cannot identify an optimal quantity of DR. Under the current net benefits test, acquisition of "all cost-effective DR" effectively results in a wealth transfer from generators to DR resources and LMPs that are no lower than without DR. Since DR, unlike energy, has no utility, this is not an ideal test of DR cost effectiveness. In this paper, we present a) an alternative method for evaluating the cost effectiveness of economic DR in wholesale markets that makes use of unique DR supply and demand curves, and b) an alternative welfare analysis methodology that identifies maximum social welfare (optimal quantity of DR). We find that because DR has no utility beyond lowering market prices, the optimal quantity of DR does not occur at market equilibrium. Rather, it occurs at the point where potential financial gain from DR is equal to dead weight losses.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Evaluating the Cost-Effectiveness of Vaccination Programs
    Elbasha, Elamin H.
    Dasbach, Erik J.
    MATHEMATICS OF CONTINUOUS AND DISCRETE DYNAMICAL SYSTEMS, 2014, 618 : 17 - 47
  • [22] Evaluating the cost-effectiveness of therapy for acne
    Weiss, S
    Kimball, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P18 - P18
  • [23] Issues in evaluating the cost-effectiveness of dialysis
    Chertow, GM
    SEMINARS IN DIALYSIS, 1999, 12 (05) : 355 - 358
  • [24] Cost-effectiveness of evaluating the new technologies
    Kastner, TA
    MENTAL RETARDATION, 1997, 35 (06): : 475 - 476
  • [25] Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
    Slot, Matilde
    Rasmussen, Thomas Bojer
    Norgaard, Mette
    Larsen, Carsten Schade
    Ehlers, Lars Holger
    PHARMACOECONOMICS-OPEN, 2024, 8 (06) : 847 - 856
  • [26] THE CHALLENGES IN EVALUATING THE COST-EFFECTIVENESS OF COMPLEX INTERVENTIONS
    Faria, B.
    Weatherly, H.
    Kiss, N.
    Manca, A.
    Parker, G.
    Beresford, B.
    Pilkington, G.
    Fawcett, Laver A. J.
    Kanaan, M.
    Rabiee, P.
    Mann, R.
    Aspinal, F.
    VALUE IN HEALTH, 2015, 18 (07) : A727 - A728
  • [27] EVALUATING THE COST-EFFECTIVENESS OF EMPLOYEE ASSISTANCE PROGRAMS
    DECKER, JT
    STARRETT, R
    REDHORSE, J
    SOCIAL WORK, 1986, 31 (05) : 391 - 393
  • [28] A SYSTEMATIC REVIEW EVALUATING COST-EFFECTIVENESS OF ACUPUNCTURE
    Kim, S. Y.
    Lee, H.
    Park, H. J.
    VALUE IN HEALTH, 2009, 12 (07) : A255 - A255
  • [29] Evaluating cost-effectiveness in the management of neuroendocrine neoplasms
    White, B. E.
    Mujica-Mota, R.
    Snowsill, T.
    Gamper, E. M.
    Srirajaskanthan, R.
    Ramage, J. K.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (03): : 647 - 663
  • [30] COST-EFFECTIVENESS CRITERIA FOR EVALUATING TRANSPORTATION ALTERNATIVES
    BUTTERWO.AV
    OPERATIONS RESEARCH, 1966, S 14 : B121 - &